Acute Promyelocytic Leukemia - 34 Studies Found
Terminated |
: Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia : Acute Promyelocytic Leukemia : 2009-09-25 :
|
Recruiting |
: French Registry of First-line Treatment of Acute Promyelocytic Leukemia : Acute Promyelocytic Leukemia : 2016-09-22 |
Completed |
: Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia : Acute Promyelocytic Leukemia : 2013-03-28 : Other: Health Related Quality of Life (HRQOL) measures Other Names:
|
Withdrawn |
: New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia : Acute Promyelocytic Leukemia : 2008-04-28 :
|
Active, not recruiting |
: Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy : Acute Promyelocytic Leukemia : 2011-07-27 : Drug: Tretinoin and Arsenic Trioxide See Detailed Description |
Completed |
: Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) : Acute Promyelocytic Leukemia : 2007-07-19 :
|
Completed |
: AIDA 2000 Guidelines : Acute Promyelocytic Leukemia : 2010-02-05 : Drug: all-trans retinoic acid (ATRA) |
Recruiting |
: Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL : Acute Promyelocytic Leukemia : 2012-12-06 :
|
Completed |
: All-trans Retinoic Acid, and Arsenic +/- Gemtuzumab : Acute Promyelocytic Leukemia : 2006-12-15 :
|
Completed |
: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia :
|